"This deal establishes a partnership that utilizes BMP Sunstone's unique insight in the women's healthcare market, as well as the company's proven expertise in marketing niche pharmaceutical products to underserved patient populations in China," said Dr. Wu Xiao Bing, Pfizer China Country Manager. "Though it seeks to serve a specially targeted market, this partnership demonstrates Pfizer's commitment to improving the health and well-being of the Chinese people at every stage of their lives."

"We are very excited about our partnership with Pfizer," said Mr. Gao Xiao Ying, CEO and Director of BMP Sunstone. "Depo-Provera is a great addition to our established women's health marketing and distribution portfolio in China. The product has already been approved by the China SFDA, and will be immediately marketable -- benefiting many women who suffer from endometriosis. We are expecting to make Depo-Provera one of the cornerstone products at BMP China, and for it to drive our business growth as we introduce it to the marketplace."

About Pfizer:

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

In China, our mission is to meet the diverse medical needs of the country's 1.3 billion population in an innovative, socially responsible and commercially viable manner. We offer a broad portfolio of innovative medicines, actively partnering with healthcare providers, academics, and authorities to serve Chinese patients and to support the rapid development of the country's healthcare system.

For more information, please visit http://www.Pfizer.com.cn .

About BMP Sunstone:

BMP Sunstone Corporation ("BMP Sunstone" or the "Company") is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Through Sunstone Pharmaceutical Co. Ltd., the Company manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold throughout the country in approximately 120,000 pharmacies. The Company also markets a portfolio of products under exclusive multi-year licenses into China, primarily focused on women's health and pediatrics, as well as provides pharmaceutical distribution services through subsidiaries in Beijing and Shanghai. BMP Sunstone's main office is in Beijing, with a U.S. office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .